Four-year clinical outcomes of the OLIVUS-Ex (impact of Olmesartan on progression of coronary atherosclerosis: Evaluation by intravascular ultrasound) extension trial

Atherosclerosis

Volumn 220, Issue 1, 2012, Pages 134-138

  Hirohata, Atsushi ^a   Yamamoto, Keizo ^a   Miyoshi, Toru ^e   Hatanaka, Kunihiko ^b   Hirohata, Satoshi ^b   Yamawaki, Hitoshi ^c   Komatsubara, Issei ^d   Hirose, Eiki ^a   Kobayashi, Yuhei ^a   Ohkawa, Keisuke ^a   Ohara, Minako ^a   Takafuji, Hiroya ^a   Sano, Fumihiko ^a   Toyama, Yuko ^a   Kusachi, Shozo ^b   Ohe, Tohru ^a   Ito, Hiroshi ^e  

^a THE SAKAKIBARA HEART INSTITUTE OF OKAYAMA   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c Tottori City Hospital   (Japan)

^d Tsuyama Central Hospital   (Japan)

^e OKAYAMA UNIVERSITY   (Japan)

Author keywords

Angiotensin; Arteriosclerosis; Atherosclerosis; Prevention; Ultrasonics

Indexed keywords

OLMESARTAN;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; INTRAVASCULAR ULTRASOUND; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SIDE EFFECT; STABLE ANGINA PECTORIS; STROKE; SURVIVAL RATE;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; CEREBROVASCULAR DISORDERS; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY DISEASE; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HEART DISEASES; HUMANS; IMIDAZOLES; JAPAN; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TETRAZOLES; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84155172795     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.10.013     Document Type: Article

References (29)

1. Dohi T., Miyauchi K., Okazaki S., et al. Early intensive statin treatment for six months improves long-term clinical outcomes in patients with acute coronary syndrome (extended-ESTABLISH trial): a follow-up study. Atherosclerosis 2009, 210:497-502.
2. Jensen L.O., Thayssen P., Pedersen K.E., Stender S., Haghfelt T. Regression of coronary atherosclerosis by simvastatin: a serial intravascular ultrasound study. Circulation 2004, 110:265-270.
3. Kawasaki M., Sano K., Okubo M., et al. Volumetric quantitative analysis of tissue characteristics of coronary plaques after statin therapy using three-dimensional integrated backscatter intravascular ultrasound. J Am Coll Cardiol 2005, 45:1946-1953.
4. Nicholls S.J., Hsu A., Wolski K., et al. Intravascular ultrasound-derived measures of coronary atherosclerotic plaque burden and clinical outcome. J Am Coll Cardiol 2010, 55:2399-2407.
5. Nicholls S.J., Tuzcu E.M., Sipahi I., et al. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis. JAMA 2007, 297:499-508.
6. Nissen S.E., Nicholls S.J., Sipahi I., et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 2006, 295:1556-1565.
7. Nissen S.E., Nicholls S.J., Wolski K., et al. Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial. JAMA 2008, 299:1561-1573.
8. Nissen S.E., Tuzcu E.M., Libby P., et al. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. JAMA 2004, 292:2217-2225.
9. Nissen S.E., Tuzcu E.M., Schoenhagen P., et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 2004, 291:1071-1080.
10. Okazaki S., Yokoyama T., Miyauchi K., et al. Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study. Circulation 2004, 110:1061-1068.
11. Sarno G., Lerman A., Bae J.H., et al. Multicenter assessment of coronary allograft vasculopathy by intravascular ultrasound-derived analysis of plaque composition. Nat Clin Pract Cardiovasc Med 2009, 6:61-69.
12. Nicholls S.J., Tuzcu E.M., Crowe T., et al. Relationship between cardiovascular risk factors and atherosclerotic disease burden measured by intravascular ultrasound. J Am Coll Cardiol 2006, 47:1967-1975.
13. Nicholls S.J., Tuzcu E.M., Wolski K., et al. Coronary artery calcification and changes in atheroma burden in response to established medical therapies. J Am Coll Cardiol 2007, 49:263-270.
14. Rodriguez-Granillo G.A., Agostoni P., Garcia-Garcia H.M., et al. Meta-analysis of the studies assessing temporal changes in coronary plaque volume using intravascular ultrasound. Am J Cardiol 2007, 99:5-10.
15. Schartl M., Bocksch W., Koschyk D.H., et al. Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease. Circulation 2001, 104:387-392.
16. Stone G.W., Maehara A., Lansky A.J., et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med 2011, 364:226-235.
17. Hirohata A., Yamamoto K., Miyoshi T., et al. Impact of olmesartan on progression of coronary atherosclerosis a serial volumetric intravascular ultrasound analysis from the OLIVUS (impact of Olmesarten on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) trial. J Am Coll Cardiol 2010, 55:976-982.
18. Nakamura M., Yock P.G., Bonneau H.N., et al. Impact of peri-stent remodeling on restenosis: a volumetric intravascular ultrasound study. Circulation 2001, 103:2130-2132.
19. Zhang C., Hein T.W., Wang W., Kuo L. Divergent roles of angiotensin II AT1 and AT2 receptors in modulating coronary microvascular function. Circ Res 2003, 92:322-329.
20. Sawada T., Yamada H., Dahlof B., Matsubara H. Effects of valsartan on morbidity and mortality in uncontrolled hypertensive patients with high cardiovascular risks: KYOTO HEART Study. Eur Heart J 2009, 30:2461-2469.
21. Agata J., Ura N., Yoshida H., et al. Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme. Hypertens Res 2006, 29:865-874.
22. Naya M., Tsukamoto T., Morita K., et al. Olmesartan, but not amlodipine, improves endothelium-dependent coronary dilation in hypertensive patients. J Am Coll Cardiol 2007, 50:1144-1149.
23. Yusuf S., Teo K., Anderson C., et al. Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial. Lancet 2008, 372:1174-1183.
24. Kubo T., Maehara A., Mintz G.S., et al. The dynamic nature of coronary artery lesion morphology assessed by serial virtual histology intravascular ultrasound tissue characterization. J Am Coll Cardiol 2010, 55:1590-1597.
25. Hartmann M., von Birgelen C., Mintz G.S., et al. Relation between plaque progression and low-density lipoprotein cholesterol during aging as assessed with serial long-term (> or =12 months) follow-up intravascular ultrasound of the left main coronary artery. Am J Cardiol 2006, 98:1419-1423.
26. Hartmann M., von Birgelen C., Mintz G.S., Verhorst P.M., Erbel R. Relation between baseline plaque burden and subsequent remodelling of atherosclerotic left main coronary arteries: a serial intravascular ultrasound study with long-term (> or =12 months) follow-up. Eur Heart J 2006, 27:1778-1784.
27. von Birgelen C., Hartmann M., Mintz G.S., Baumgart D., Schmermund A., Erbel R. Relation between progression and regression of atherosclerotic left main coronary artery disease and serum cholesterol levels as assessed with serial long-term (> or =12 months) follow-up intravascular ultrasound. Circulation 2003, 108:2757-2762.
28. von Birgelen C., Hartmann M., Mintz G.S., et al. Relationship between cardiovascular risk as predicted by established risk scores versus plaque progression as measured by serial intravascular ultrasound in left main coronary arteries. Circulation 2004, 110:1579-1585.
29. Waseda K., Ozaki Y., Takashima H., et al. Impact of angiotensin II receptor blockers on the progression and regression of coronary atherosclerosis: an intravascular ultrasound study. Circ J 2006, 70:1111-1115.